SPY366.02+3.96 1.09%
DIA298.44+1.82 0.61%
IXIC12,355.11+156.37 1.28%

Kintara Therapeutics Q1 EPS $(1.33) Down From $(0.21) YoY

Kintara Therapeutics (NASDAQ:KTRA) reported quarterly losses of $(1.33) per share. This is a 533.33 percent decrease over losses of $(0.21) per share from the same period last year.

· 11/13/2020 08:08
Kintara Therapeutics (NASDAQ:KTRA) reported quarterly losses of $(1.33) per share. This is a 533.33 percent decrease over losses of $(0.21) per share from the same period last year.